非霍奇金淋巴瘤化疗后广泛皮肤钙质沉着症并自发消退
本文报告一例30岁女性IV期非霍奇金淋巴瘤患者,基线FDG PET/CT显示淋巴结肿大伴乳腺及骨骼受累,接受3周期R-CHOP化疗后中期PET/CT示部分治疗反应,但出现乳腺FDG高摄取粗大钙化及肘部、骨盆和大腿皮肤皮下类似钙化,治疗后PET/CT显示皮肤钙质沉着显著消退,提示化疗后特发性皮肤钙质沉着症可快速自发消退。
要点
- 非霍奇金淋巴瘤化疗后可出现FDG高摄取的皮肤及皮下钙化,需与肿瘤进展鉴别。
- 本例皮肤钙质沉着症在治疗后PET/CT上显示显著自发消退。
- 中期PET/CT评估治疗反应时需注意识别化疗相关良性钙化改变。
核心结论
- 本例报告了非霍奇金淋巴瘤患者化疗后出现特发性皮肤钙质沉着症并快速自发消退。
研究设计与样本
- 个案报道,描述一例30岁女性IV期非霍奇金淋巴瘤患者的临床及FDG PET/CT影像经过。
主要发现
- 基线FDG PET/CT显示淋巴结肿大伴乳腺及骨骼受累。
- 患者接受3周期R-CHOP化疗,化疗前后生化检查无异常。
- 中期FDG PET/CT显示部分治疗反应,但乳腺出现FDG高摄取粗大钙化,肘部、骨盆和大腿皮肤皮下区域可见类似钙化。
- 治疗后PET/CT显示皮肤钙质沉着显著消退。
临床怎么用
- 淋巴瘤化疗后PET/CT出现FDG高摄取钙化灶时,应结合临床考虑化疗相关皮肤钙质沉着症等良性改变。
局限性
- 本文为单例个案报道,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report the case of a 30-year-old woman with stage IV, non-Hodgkin lymphoma. Baseline F-FDG PET/CT scan revealed lymphadenopathy with breasts and skeletal involvement. She received 3 cycles of R-CHOP (rituximab, cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone) chemotherapy without significant adverse effects. Biochemical examinations before and after chemotherapies were unremarkable. InterimF-FDG PET/CT showed a partial treatment response. However, there was an appearance of FDG-avid coarse calcification in breasts. Cutaneous and subcutaneous regions of elbows, pelvis, and thighs showed similar calcifications. Posttherapy PET/CT showed a significant resolution of calcinosis cutis. This case presents a postchemotherapy idiopathic calcinosis cutis with rapid spontaneous resolution.
引用
- Mishra V, Madurai Kalimuthu L, Singh P, et al. Extensive Postchemotherapy Calcinosis Cutis in a Non-Hodgkin Lymphoma Patient With Spontaneous Resolution. Clin Nucl Med. 2021. PMID: 33181749. doi:10.1097/RLU.0000000000003383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。